MedTrace Logo

Short-Term Transcutaneous or Epidural Spinal Stimulation for Enabling Motor Function in Humans With SCI

NCT05095454 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2024-07-09

Study results available
· View outcomes & findings →

Summary

A study comparing short-term delivery of epidural spinal stimulation versus transcutaneous spinal stimulation.

Conditions

  • Paraplegia
  • Tetraplegia
  • Paralysis
  • Quadraplegia

Interventions

DEVICE

Percutaneous epidural electrical spinal stimulation

Abbott percutaneous trial lead for epidural neurostimulation (Model 3086) Ripple Neuromed Nomad Neurostimulation System

DEVICE

Transcutaneous electrical spinal stimulation

Digitimer DS8R Bipolar Constant Current Stimulator

Sponsors & Collaborators

  • Kristin Zhao, PhD

    lead OTHER

Principal Investigators

  • Kristin D Zhao, Ph.D. · Mayo Clinic

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-04
Primary Completion
2023-03-30
Completion
2023-03-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05095454 on ClinicalTrials.gov